Obexelimab
Obexelimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Obexelimab is under investigation in clinical trial NCT02725515 (A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus).
| Trade Name | Obexelimab |
| Generic | Obexelimab |
| Obexelimab Other Names | Obexelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Obexelimab
